Back
ProShares Short 20+ Yr Treasury Vs. Alnylam Pharmaceuticals, Inc. Industry Stock Comparison
Buy
70
TBF
ProShares Short 20+ Yr Treasury
Last Price:
$24.11
Seasonality Move:
-0.97%
Sell
41
ALNY
Alnylam Pharmaceuticals, Inc.
Last Price:
$397.69
Seasonality Move:
1.76%
Buy
70
ProShares Short 20+ Yr Treasury (TBF)
is a Buy
Is ProShares Short 20+ Yr Treasury a Buy, Sell or Hold?
-
The current ProShares Short 20+ Yr Treasury [TBF] share price is $24.12. The Score for TBF is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
TBF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Alnylam Pharmaceuticals, Inc. (ALNY)
is a Sell
Is Alnylam Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals, Inc. [ALNY] share price is $397.65. The Score for ALNY is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TBF Stock Price Chart
What is ProShares Short 20+ Yr Treasury's stock price today?
-
The ProShares Short 20+ Yr Treasury share price today is $24.12Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TBF is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals, Inc.'s stock price today?
-
The Alnylam Pharmaceuticals, Inc. share price today is $397.65Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.
TBF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.67 | Buy |
| Relative Strength Index (14 RSI): | 55.34 | Buy |
| Chaikin Money Flow: | 80480 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.74 - 24.2) | Buy |
| Bollinger Bands (100): | (23.45 - 24.33) | Buy |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -12.2 | Sell |
| Relative Strength Index (14 RSI): | 37.79 | Sell |
| Chaikin Money Flow: | -650289 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (391.88 - 446.1) | Sell |
| Bollinger Bands (100): | (422.72 - 470.24) | Sell |
TBF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.03 | Buy |
| 20-day SMA: | 24.06 | Buy |
| 50-day SMA: | 23.74 | Buy |
| 200-day SMA: | 24.2 | Sell |
| 8-day EMA: | 21.51 | Buy |
| 20-day EMA: | 14.27 | Buy |
| 50-day EMA: | 7.27 | Buy |
| 200-day EMA: | 2.07 | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 400.21 | Sell |
| 20-day SMA: | 411.45 | Sell |
| 50-day SMA: | 436.15 | Sell |
| 200-day SMA: | 371.13 | Buy |
| 8-day EMA: | 399.81 | Sell |
| 20-day EMA: | 410 | Sell |
| 50-day EMA: | 426.22 | Sell |
| 200-day EMA: | 383.9 | Buy |
ProShares Short 20+ Yr Treasury Earnings Growth & TBF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Alnylam Pharmaceuticals, Inc. Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.23 per share, and an increase next year of $6.60 per share.
ProShares Short 20+ Yr Treasury Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||